Historical perspective: Gut dysbiosis and hypertension

Physiological Genomics

Volumn 47, Issue 10, 2015, Pages 443-446

  Honour, John William ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; STEROID RECEPTOR;

CLINICAL TRIAL (TOPIC); DYSBIOSIS; EDITORIAL; ENTEROHEPATIC CIRCULATION; HUMAN; HYPERTENSION; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; STEROID METABOLISM; ANIMAL; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; HYPERTENSION;

EID: 84943253507     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00063.2015     Document Type: Editorial

References (47)

1. Attard G, Belldegrun AS, de Bono JS. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU Int 96: 1241-1246, 2005.
2. Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man. J Clin Invest 45: 1946-1954, 1966.
3. Bokkenheuser VD, Winter J, Honour JW, Shackleton CHL. Reduction of aldosterone by anaerobic bacteria: origin of urinary 21-deoxy metabolites in man. J Steroid Biochem 11: 1145-1149, 1979.
4. Bokkenheuser VD, Winter J, Morris GN, Locascio S. Steroid desmolase synthesis by Eubacterium desmolans and Clostridium cadavaris. Appl Environ Microbiol 52: 1153-1156, 1986.
5. Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Blædel T, Håkansson J, Dalsgaard TK, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH. Dietary modulation of the gut microbiota-a randomised controlled trial in obese postmenopausal women. Br J Nutr 2: 1-12, 2015.
6. Brem AS, Bina RB, King T, Morris DJ. 11BetaOH-progesterone affects vascular glucocorticoid metabolism and contractile response. Hypertension 30: 449-454, 1997.
7. Davis EA, Morris DJ. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol Cell Endocrinol 78: 1-6, 1991.
8. Davis-Richardson AG, Triplett EW. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 58: 1386-1393, 2015.
9. Devkota S, Chang EB. Interactions between diet, bile acid metabolism, gut, microbiota, and inflammatory bowel diseases. Dig Dis 33: 351-356, 2015.
10. Eriksson H, Gustafsson JA, Sjövall J. Steroids in germfree and conventional rats. 21-Dehydroxylation by intestinal microorganisms. Eur J Biochem 9: 550-554, 1969.
11. Feighner SD, Bokkenheuser VD, Winter J, Hylemon PB. Characterization of a C21 neutral steroid hormone transforming enzyme, 21-dehydroxylase, in crude cell extracts of Eubacterium lentum. Biochim Biophys Acta 574: 154-163, 1979.
12. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 20: 16079-16094, 2014.
13. Fiselier TJW, Otten BJ, Monnens LAH, van Munster PJJ, Honour JW. Low renin, low aldosterone hypertension and abnormal cortisol metabolism in a 19 month old child. Horm Res 16: 107-114, 1982.
14. Fraillon D, Wynne KN, Funder JW. Further studies on neomycin and experimental hypertension. Clin Exp Pharmacol Physiol 11: 339-341, 1984.
15. Goto Y, Kurashima Y, Kiyono H. The gut microbiota and inflammatory bowel disease. Curr Opin Rheumatol 27: 388-396, 2015.
16. Gustafsson JA. Control of gene expression by novel metabolic intermediates. J Steroid Biochem Mol Biol [Epub ahead of print].
17. Honour JW, Tourniaire J, Biglieri EG, Shackleton CHL. Urinary steroid excretion in 17-hydroxylase deficiency. J Steroid Biochem 9: 495-506, 1978.
18. Honour JW. Hypertensive effect of steroids produced in the intestine by bacterial metabolism (Abstract). Serono Symposium: Endocrinology of Hypertension. Padua, Italy: October 1981, p. 30.
19. Honour JW, Kent J. Dissociation of the hypertensive effect from other physiological responses to steroids in rats (Abstract). Proceedings of the Society for Endocrinology 164th Meeting. London: Society of Endocrinology, 1981, p 7.
20. Honour JW, Millar G, Roitman E, Shackleton CHL. Steroid excretion in man during suppression and stimulation of adrenals in 17-hydroxylase deficiency syndrome. J Clin Endocrinol Metab 52: 1039-1042, 1981.
21. Honour JW, Ganten U. Effect of neomycin on hypertension in normal and SHR rats. Sixth International Congress on Hormonal Steroids.Jerusalem, September 1982.
22. Honour JW. The possible involvement of intestinal bacteria in steroidal hypertension. Endocrinology 110: 285-287, 1982.
23. Honour JW, Dillon MJ, Levin M, Shah V. Fatal, low renin hypertension due to a defect of cortisol metabolism. Arch Dis Child 58: 1018-1020, 1983.
24. Honour JW, Borriello SP, Ganten U, Honour P. Antibiotics attenuate experimental hypertension in rats. J Endocrinol 105: 347-350, 1985.
25. Hwang I, Park YJ, Kim YR, Kim YN, Ka S, Lee HY, Seong JK, Seok YJ, Kim JB. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J 29: 2397-2411, 2015.
26. Ingram BW, Funder JW. Neomycin and experimental hypertension. Clin Exp Pharmacol Physiol 9: 331-333, 1982.
27. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol 308: G351-G363, 2015.
28. Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S, Joe B. Evidence for a link between gut microbiota and hypertension in the Dahl rat model. Physiol Genomics 47: 187-197, 2015.
29. Morris DJ, Latif SA, Hardy MP, Brem AS. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol. J Steroid Biochem Mol Biol 104: 161-168, 2007.
30. Morris DJ, Latif SA, Brem AS. An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndrome. Steroids 79: 44-48, 2014.
31. Morris DJ. Why do humans have two glucocorticoids: a question of intestinal fortitude. Steroids 102: 32-38, 2015.
32. Nami Y, Haghshenas B, Abdullah N, Barzegari A, Radiah D, Rosli R, Khosroushahi AY. Probiotics or antibiotics: future challenges in medicine. J Med Microbiol 64: 137-146, 2015.
33. Panzer AR, Lynch SV. Influence and effect of the human microbiome in allergy and asthma. Curr Opin Rheumatol 27: 373-380, 2015.
34. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 110: 4410-4415, 2013.
35. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60, 2012.
36. Scoggins BA, Coghlan JP, Denton DA, Mills EH, Nelson MA, Spence CD, Whitworth JA. How do adrenocortical steroid hormones produce hypertension? Clin Exper Hypertens A 6: 315-328, 1984.
37. Scott KP, Antoine JM, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 26: 25877, 2015.
38. Shackleton CHL, Biglieri EG, Roitman E, Honour JW. Metabolism of radiolabelled corticosterone in an adult with 17-hydroxylase deficiency syndrome. J Clin Endocrinol Metab 48: 974-982, 1979.
39. Shackleton CHL, Winter J, Bokkenheuser VD, Honour JW. Urinary metabolites of 18-hydroxylated corticosteroids: Microbial preparation of reference compounds. J Steroid Biochem 11: 1141-1144, 1979.
40. Shackleton CHL, Honour JW, Dillon MJ, Chantler C, Jones RWA. Hypertension in a four-year-old child: Gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J Clin Endocrinol Metab 50: 786-792, 1980.
41. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821-824, 1987.
42. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 82: 340-349, 1988.
43. Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives. J Steroid Biochem Mol Biol 104: 312-320, 2007.
44. Tralau T, Sowada J, Luch A. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? Expert Opin Drug Metab Toxicol 11: 411-425, 2015.
45. Tresham J, Coghlan JP, Denton DA, Scoggins BA, Whitworth JA. Failure of neomycin to modify ACTH induced hypertension in sheep. Clin Exp Pharmacol Physiol 11: 645-647, 1984.
46. van Best N, Jansen PL, Rensen SS. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. Hepatol Int 9: 406-415, 2015.
47. Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, Sahay B, Pepine CJ, Raizada MK, Mohamadzadeh M. Gut dysbiosis is linked to hypertension. Hypertension 65: 1331-1340, 2015.